Last updated on July 2019

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ulcerative Colitis | Crohn's Disease
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with Crohn's disease or ulcerative colitis who started treatment with this drug
  • Patients who received this drug for the first time at the medical institution after the day of launch of this drug.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.